A citation-based method for searching scientific literature

Ajay Varanasi, Natalie Bellini, Deepti Rawal, Mehul Vora, Antoine Makdissi, Sandeep Dhindsa, Ajay Chaudhuri, Paresh Dandona. Eur J Endocrinol 2011
Times Cited: 97



Michael Elashoff, Aleksey V Matveyenko, Belinda Gier, Robert Elashoff, Peter C Butler. Gastroenterology 2011
Times Cited: 534




List of shared articles



Times cited

Current issues in GLP-1 receptor agonist therapy for type 2 diabetes.
Zachary T Bloomgarden, Lawrence Blonde, Alan J Garber, Carol H Wysham. Endocr Pract 2012
7


Efficacy and safety of exenatide once weekly: an overview of the DURATION trials.
Christophe Em De Block, Luc F Van Gaal. Expert Rev Endocrinol Metab 2012
2

GLP-1 receptor agonists in type 1 diabetes: a proof-of-concept approach.
Isabella Crisci, Michele Aragona, Konstantina Savvina Politi, Giuseppe Daniele, Stefano Del Prato. Acta Diabetol 2015
10

Synergy Between Gαz Deficiency and GLP-1 Analog Treatment in Preserving Functional β-Cell Mass in Experimental Diabetes.
Allison L Brill, Jaclyn A Wisinski, Mark T Cadena, Mary F Thompson, Rachel J Fenske, Harpreet K Brar, Michael D Schaid, Renee L Pasker, Michelle E Kimple. Mol Endocrinol 2016
13

Liraglutide as Adjunct to Insulin Treatment in Patients with Type 1 Diabetes: A Systematic Review and Meta-analysis.
Patoulias Dimitrios, Doumas Michael, Kotsis Vasilios, Stavropoulos Konstantinos, Imprialos Konstantinos, Zografou Ioanna, Petidis Konstantinos, Bakatselos Spyridon, Karagiannis Asterios. Curr Diabetes Rev 2020
11

Use of non-insulin therapies for type 1 diabetes.
Satish K Garg, Aaron W Michels, Viral N Shah. Diabetes Technol Ther 2013
8

The potential of incretin-based therapies in type 1 diabetes.
Chen S Suen, Paul Burn. Drug Discov Today 2012
19


Can GLP-1 preparations be used in children and adolescents with diabetes mellitus?
Naim Shehadeh, Eena Daich, Nehama Zuckerman-Levin. Pediatr Endocrinol Rev 2014
4

Emerging gliptins for type 2 diabetes.
Avivit Cahn, Itamar Raz. Expert Opin Emerg Drugs 2013
20

Recent advances in incretin-based therapies.
David Russell-Jones, Stephen Gough. Clin Endocrinol (Oxf) 2012
49